| PERIOD ENDING | 29-Jun-08 | 30-Mar-08 | 30-Dec-07 | 30-Sep-07 | | Total Revenue | 168,427 | 159,723 | 158,040 | 140,326 | | Cost of Revenue | 55,758 | 53,846 | 52,237 | 49,013 | | | Gross Profit | 112,669 | 105,877 | 105,803 | 91,313 | | | Operating Expenses | | Research Development | 34,367 | 33,752 | 33,174 | 33,058 | | Selling General and Administrative | 30,521 | 30,861 | 28,552 | 29,443 | | Non Recurring |
-
| 1,556 |
-
| 1,636 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 47,781 | 39,708 | 44,077 | 27,176 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,539 | (2,861) | 4,866 | 5,753 | | Earnings Before Interest And Taxes | 49,320 | 36,847 | 48,943 | 32,929 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 49,320 | 36,847 | 48,943 | 32,929 | | Income Tax Expense | 17,673 | 14,082 | 17,073 | 10,349 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 31,647 | 22,765 | 31,870 | 22,580 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 31,647 | 22,765 | 31,870 | 22,580 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $31,647 | $22,765 | $31,870 | $22,580 |
|
1.49% Nasdaq 
0.27%
Income Statement
